8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-13-048995
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading v354270_8k.htm…